Ono taps Receptos to identify GCPR-based drug leads
This article was originally published in Scrip
Executive Summary
In a deal which might be aimed at building up its existing R&D activities in the oncology field, Ono Pharmaceutical has tied up with Receptos for discovery research into a G-protein-coupled receptor (GPCR) related to a bioactive lipid.